The Renal Micro-Vasculopathy and Systemic Aldosterone-Renin Ratio (ARR) in Type 2 Diabetic Patients-A Retrospective Real-World Study

2型糖尿病患者肾脏微血管病变与全身醛固酮-肾素比值(ARR)的关系——一项回顾性真实世界研究

阅读:2

Abstract

OBJECTIVE: To investigate whether the imbalanced aldosterone to renin ratio (ARR) is associated with renal micro-vasculopathy in type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: Data from 471 T2DM patients were retrospectively analyzed from 2019 to 2023. Blood samples were collected for hypertensive and diabetes-related parameters at the time of admission. The patients were divided into two groups based on laboratory measurement methods: plasma renin concentration or plasma renin activity. RESULTS: This study found that dividing patients into four quartiles showed significant increases in renal microvascular damage, measured by serum creatinine (SCr) and blood urea nitrogen (BUN), in contrast to the decline pattern of cystatin C (Cys) in the highest and lowest quartiles of ARR, respectively. This pattern contrasted with the levels of the urinary albumin-to-creatinine ratio (UACR) and the estimated glomerular filtration rate (eGFR). Correlation analysis identified gender, systolic blood pressure (SBP), and kidney function markers as significantly associated with ARR. Women exhibited the highest levels of renin or aldosterone. Furthermore, multilinear regression analysis in the PDC group indicated that ARR was independently influenced by insulin requirement, antihypertensive medication, serum magnesium, diastolic blood pressure (DBP), thyroid hormone, and calcium balance. In the PRA group, glucose metabolism, calcium homeostasis, and bile acids affect ARR change. The receiver operating characteristic (ROC) curve demonstrated that ARR could serve as a predictor of renal function and UACR. CONCLUSION: The results indicated that the aberrant ARR was associated with renal glomerular injury. ARR can be employed to examine the relationship between renal injury and renin-angiotensin-aldosterone system (RAAS) activity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。